Literature DB >> 10543357

Mumps: a current epidemiologic pattern as a necessary background for the choice of a vaccination strategy.

C Zotti1, O Ossola, R Barberis, A Castella, A M Ruggenini.   

Abstract

Before the measles mumps rubella (MMR) vaccination was widely offered, the epidemiologic data about mumps (morbidity, immunization level, vaccine coverage) were analyzed in Piedmont region (Italy). The disease had a 3- to 5-year epidemic recurrence with morbidity rate between 40 and 150/100,000; the surveillance conducted by 'sentinel' pediatricians showed that the notifications underestimated the real data by about 5- to 7-fold. The 12-year-old subjects showed an immunization level (reached by the disease or the vaccination) of about 50% and their parents tended to refuse the MMR vaccination. Only 54% of the 3- to 5-year-old children received the MMR vaccine in the second year of life and the frequency of the vaccination failure was about 10%. The strategy of vaccination should take into account this epidemiologic pattern, to program an offer adequate to reach mumps control/elimination; the strategy of our region should include the active offer in the second year of life to reach higher coverage, a second offer at 4-6 and/or 12 years of life, when other vaccinations are given and the choice of a highly efficacious vaccine. The improvement of the notification system could also allow a more sensitive surveillance of epidemiologic patterns.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10543357     DOI: 10.1023/a:1007691509030

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  12 in total

1.  Mumps epidemic in Portugal despite high vaccine coverage - preliminary report.

Authors:  J.A. Dias; M Cordeiro; M.A. Afzal; M.G. Freitas; M.R. Morgado; J.L. Silva; L.M. Nunes; M.G. Lima; F Avilez
Journal:  Euro Surveill       Date:  1996-04

2.  Mumps outbreak in a highly vaccinated population.

Authors:  B S Hersh; P E Fine; W K Kent; S L Cochi; L H Kahn; E R Zell; P L Hays; C L Wood
Journal:  J Pediatr       Date:  1991-08       Impact factor: 4.406

3.  Changes of the immunological patterns against measles, mumps and rubella. A vaccination programme studied 3 to 7 years after the introduction of a two-dose schedule.

Authors:  B Christenson; M Böttiger
Journal:  Vaccine       Date:  1991-05       Impact factor: 3.641

4.  Field evaluation of the clinical effectiveness of vaccines against pertussis, measles, rubella and mumps. The Benevento and Compobasso Pediatricians Network for the Control of Vaccine-Preventable Diseases.

Authors: 
Journal:  Vaccine       Date:  1998-05       Impact factor: 3.641

5.  Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme.

Authors:  K Broliden; E R Abreu; M Arneborn; M Böttiger
Journal:  Vaccine       Date:  1998 Jan-Feb       Impact factor: 3.641

6.  Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule.

Authors:  N Gay; E Miller; L Hesketh; P Morgan-Capner; M Ramsay; B Cohen; D Brown
Journal:  Commun Dis Rep CDR Rev       Date:  1997-02-07

7.  A large outbreak of mumps in the postvaccine era.

Authors:  M Wharton; S L Cochi; R H Hutcheson; J M Bistowish; W Schaffner
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

8.  Perspectives on the relative resurgence of mumps in the United States.

Authors:  S L Cochi; S R Preblud; W A Orenstein
Journal:  Am J Dis Child       Date:  1988-05

9.  An outbreak of mumps in a population partially vaccinated with the Rubini strain.

Authors:  D Germann; A Ströhle; K Eggenberger; C A Steiner; L Matter
Journal:  Scand J Infect Dis       Date:  1996

10.  Changing epidemiology of mumps and its impact on university campuses.

Authors:  D M Sosin; S L Cochi; R A Gunn; C E Jennings; S R Preblud
Journal:  Pediatrics       Date:  1989-11       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.